CAP
An overwhelming volume of arbitration requests has made it difficult for providers, including labs, to quickly challenge and resolve payment disputes under the law.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix
News items for the week of Nov. 21, 2022.
CAP Survey Sees Labs Aware of New Kidney Function Equations Aimed at Reducing Racial Disparities
Premium
The survey also found that while implementation lagged awareness, roughly 30 percent of labs had switched to the new equations months after their introduction.
AMP, CAP Release Guidelines for Use of In Silico Approaches for Validating NGS Data Pipelines
Labs should not let in silico data supplant physical specimens in bioinformatic validation and should understand the limitations of such data.
Sep 13, 2022
Aug 19, 2022
Aug 8, 2022
Dec 23, 2021
Dec 21, 2021
Nov 16, 2021
Aug 26, 2021
Jan 7, 2021